258 related articles for article (PubMed ID: 1324056)
1. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
Filep J; Hermán F; Braquet P
Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
[TBL] [Abstract][Full Text] [Related]
3. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
Wallace JL; Hogaboam CM; McKnight GW
Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
[TBL] [Abstract][Full Text] [Related]
5. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
6. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats.
Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB
J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149
[TBL] [Abstract][Full Text] [Related]
7. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Becker K; Lueddeckens G; Grupe R; Förster W
Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
[TBL] [Abstract][Full Text] [Related]
8. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
Konturek SJ; Brzozowski T; Drozdowicz D; Garlicki J; Beck G
Eur J Pharmacol; 1989 May; 164(2):285-92. PubMed ID: 2759176
[TBL] [Abstract][Full Text] [Related]
9. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
10. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
Teather LA; Magnusson JE; Wurtman RJ
Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
[TBL] [Abstract][Full Text] [Related]
12. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
13. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
Braquet P; Etienne A; Mencia-Huerta JM; Clostre F
Eur J Pharmacol; 1988 Jun; 150(3):269-76. PubMed ID: 3046952
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
Etienne A; Thonier F; Braquet P
Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
[TBL] [Abstract][Full Text] [Related]
15. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
[TBL] [Abstract][Full Text] [Related]
16. Presence of specific platelet-activating factor binding sites in the rat retina.
Thierry A; Doly M; Braquet P; Cluzel J; Meyniel G
Eur J Pharmacol; 1989 Apr; 163(1):97-101. PubMed ID: 2545464
[TBL] [Abstract][Full Text] [Related]
17. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
19. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
